메뉴 건너뛰기




Volumn 138, Issue 3, 2014, Pages 390-394

Lung adenocarcinoma biomarker incidence in hispanic versus non-hispanic white patients

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

EID: 84895521595     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2013-0225-OA     Document Type: Article
Times cited : (12)

References (30)
  • 2
    • 84871036375 scopus 로고    scopus 로고
    • Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010
    • [published correction appears in Lancet. 2013;381(9867): 628]
    • Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2013;381(9867): 628]. Lancet. 2012;380(9859): 2095-2128.
    • (2012) Lancet , vol.380 , Issue.9859 , pp. 2095-2128
    • Lozano, R.1    Naghavi, M.2    Foreman, K.3
  • 4
    • 84865987833 scopus 로고    scopus 로고
    • The influence of hispanic ethnicity on nonsmall cell lung cancer histology and patient survival: An analysis of the survival epidemiology and end results database
    • Saeed AM, Toonkel R, Glassberg MK, et al. The influence of Hispanic ethnicity on nonsmall cell lung cancer histology and patient survival: an analysis of the Survival, Epidemiology, and End Results database. Cancer. 2012;118(18): 4495-4501.
    • (2012) Cancer , vol.118 , Issue.18 , pp. 4495-4501
    • Saeed, A.M.1    Toonkel, R.2    Glassberg, M.K.3
  • 5
    • 84875278514 scopus 로고    scopus 로고
    • Cancer genes in lung cancer: Racial disparities: Are there any?
    • El-Telbany A, Ma PC. Cancer genes in lung cancer: racial disparities: are there any? Genes Cancer. 2012;3(7-8): 467-480.
    • (2012) Genes Cancer , vol.3 , Issue.7-8 , pp. 467-480
    • El-Telbany, A.1    Ma, P.C.2
  • 6
    • 79951761631 scopus 로고    scopus 로고
    • Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancer
    • Cote ML, Haddad R, Edwards DJ, et al. Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancer. J Thorac Oncol. 2011;6(3): 627-630.
    • (2011) J Thorac Oncol , vol.6 , Issue.3 , pp. 627-630
    • Cote, M.L.1    Haddad, R.2    Edwards, D.J.3
  • 7
    • 79954574430 scopus 로고    scopus 로고
    • Characterization of epidermal growth factor receptor mutations in non-small-cell lung cancer patients of African-American ancestry
    • Harada T, Lopez-Chavez A, Xi L, Raffeld M, Wang Y, Giaccone G. Characterization of epidermal growth factor receptor mutations in non-small-cell lung cancer patients of African-American ancestry. Oncogene. 2011;30(15): 1744-1752.
    • (2011) Oncogene , vol.30 , Issue.15 , pp. 1744-1752
    • Harada, T.1    Lopez-Chavez, A.2    Xi, L.3    Raffeld, M.4    Wang, Y.5    Giaccone, G.6
  • 8
    • 73949154122 scopus 로고    scopus 로고
    • Genetic abnormalities of the EGFR pathway in African American Patients with non-small-cell lung cancer
    • Leidner RS, Fu P, Clifford B, et al. Genetic abnormalities of the EGFR pathway in African American Patients with non-small-cell lung cancer. J Clin Oncol. 2009;27(33): 5620-5626.
    • (2009) J Clin Oncol , vol.27 , Issue.33 , pp. 5620-5626
    • Leidner, R.S.1    Fu, P.2    Clifford, B.3
  • 9
    • 78651087933 scopus 로고    scopus 로고
    • Frequency of EGFR and KRAS mutations in lung adenocarcinomas in African Americans
    • Reinersman JM, Johnson ML, Riely GJ, et al. Frequency of EGFR and KRAS mutations in lung adenocarcinomas in African Americans. J Thorac Oncol. 2011; 6(1): 28-31.
    • (2011) J Thorac Oncol , vol.6 , Issue.1 , pp. 28-31
    • Reinersman, J.M.1    Johnson, M.L.2    Riely, G.J.3
  • 10
    • 21244500107 scopus 로고    scopus 로고
    • Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas
    • Soung YH, Lee JW, Kim SY, et al. Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas. Virchows Arch. 2005;446(5): 483-488.
    • (2005) Virchows Arch , vol.446 , Issue.5 , pp. 483-488
    • Soung, Y.H.1    Lee, J.W.2    Kim, S.Y.3
  • 11
    • 79958178777 scopus 로고    scopus 로고
    • East meets West: Ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians
    • Zhou W, Christiani DC. East meets West: ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians. Chin J Cancer. 2011;30(5): 287-292.
    • (2011) Chin J Cancer , vol.30 , Issue.5 , pp. 287-292
    • Zhou, W.1    Christiani, D.C.2
  • 12
    • 33847091172 scopus 로고    scopus 로고
    • EGFR ERBB2 and KRAS Mutations in Korean Non-small Cell Lung Cancer Patients
    • Bae NC, Chae MH, Lee MH, et al. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients. Cancer Genet Cytogenet. 2007; 173(2): 107-113.
    • (2007) Cancer Genet Cytogenet , vol.173 , Issue.2 , pp. 107-113
    • Bae, N.C.1    Chae, M.H.2    Lee, M.H.3
  • 13
    • 77955092984 scopus 로고    scopus 로고
    • Spectrum of LKB1, EGFR, and KRAS mutations in Chinese lung adenocarcinomas
    • Gao B, Sun Y, Zhang J, et al. Spectrum of LKB1, EGFR, and KRAS mutations in Chinese lung adenocarcinomas. J Thorac Oncol. 2010;5(8): 1130-1135.
    • (2010) J Thorac Oncol , vol.5 , Issue.8 , pp. 1130-1135
    • Gao, B.1    Sun, Y.2    Zhang, J.3
  • 14
    • 10844231985 scopus 로고    scopus 로고
    • Mutations of the epidermal growth factor receptor gene in lung cancer: Biological and clinical implications
    • Kosaka T, Yatabe Y, Endoh H, Kuwano H, Takahashi T, Mitsudomi T. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res. 2004;64(24): 8919-8923.
    • (2004) Cancer Res , vol.64 , Issue.24 , pp. 8919-8923
    • Kosaka, T.1    Yatabe, Y.2    Endoh, H.3    Kuwano, H.4    Takahashi, T.5    Mitsudomi, T.6
  • 15
    • 80054948914 scopus 로고    scopus 로고
    • Genotyping non-small cell lung cancer (NSCLC) in Latin America
    • Arrieta O, Cardona AF, Federico Bramuglia G, et al. Genotyping non-small cell lung cancer (NSCLC) in Latin America. J Thorac Oncol. 2011;6(11): 1955-1959.
    • (2011) J Thorac Oncol , vol.6 , Issue.11 , pp. 1955-1959
    • Arrieta, O.1    Cardona, A.F.2    Federico Bramuglia, G.3
  • 17
    • 84858297956 scopus 로고    scopus 로고
    • The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers
    • Atherly AJ, Camidge DR. The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers. Br J Cancer. 2012;106(6): 1100-1106.
    • (2012) Br J Cancer , vol.106 , Issue.6 , pp. 1100-1106
    • Atherly, A.J.1    Camidge, D.R.2
  • 18
    • 69349083935 scopus 로고    scopus 로고
    • Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population
    • Rodig SJ, Mino-Kenudson M, Dacic S, et al. Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population. Clin Cancer Res. 2009;15(16): 5216-5223.
    • (2009) Clin Cancer Res , vol.15 , Issue.16 , pp. 5216-5223
    • Rodig, S.J.1    Mino-Kenudson, M.2    Dacic, S.3
  • 19
    • 70349336416 scopus 로고    scopus 로고
    • Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK
    • Shaw AT, Yeap BY, Mino-Kenudson M, et al. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK. J Clin Oncol. 2009;27(26): 4247-4253.
    • (2009) J Clin Oncol , vol.27 , Issue.26 , pp. 4247-4253
    • Shaw, A.T.1    Yeap, B.Y.2    Mino-Kenudson, M.3
  • 20
    • 80053386829 scopus 로고    scopus 로고
    • Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: A retrospective analysis
    • Shaw AT, Yeap BY, Solomon BJ, et al. Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis. Lancet Oncol. 2011;12(11): 1004-1012.
    • (2011) Lancet Oncol , vol.12 , Issue.11 , pp. 1004-1012
    • Shaw, A.T.1    Yeap, B.Y.2    Solomon, B.J.3
  • 21
    • 84870858928 scopus 로고    scopus 로고
    • Lung cancer genotype-based therapy and predictive biomarkers: Present and future
    • Cagle PT, Allen TC. Lung cancer genotype-based therapy and predictive biomarkers: present and future. Arch Pathol Lab Med. 2012;136(12): 1482-1491.
    • (2012) Arch Pathol Lab Med , vol.136 , Issue.12 , pp. 1482-1491
    • Cagle, P.T.1    Allen, T.C.2
  • 22
    • 84860582939 scopus 로고    scopus 로고
    • Advances in treatment of lung cancer with targeted therapy
    • Cagle PT, Chirieac LR. Advances in treatment of lung cancer with targeted therapy. Arch Pathol Lab Med. 2012;136(5): 504-509.
    • (2012) Arch Pathol Lab Med , vol.136 , Issue.5 , pp. 504-509
    • Cagle, P.T.1    Chirieac, L.R.2
  • 23
    • 84879635389 scopus 로고    scopus 로고
    • Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology [published online ahead of print April 3, 2013] doi:10.5858/arpa. 2012-0720-OA
    • Lindeman NI, Cagle PT, Beasley MB, et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology [published online ahead of print April 3, 2013]. Arch Pathol Lab Med. doi:10.5858/arpa. 2012-0720-OA.
    • Arch Pathol Lab Med
    • Lindeman, N.I.1    Cagle, P.T.2    Beasley, M.B.3
  • 24
    • 0003809054 scopus 로고    scopus 로고
    • American Joint Committee On CancerLung. 6th ed. New York, NY: Springer- Verlag;. Accessed March 5 2013
    • American Joint Committee on CancerLung. In: Greene FL, Page DL, Fleming ID, eds. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer- Verlag; 2002: 167-177. http://www.cancerstaging.org/products/csmanual6ed-3. pdf. Accessed March 5, 2013.
    • (2002) AJCC Cancer Staging Manual , pp. 167-177
    • Greene, F.L.1    Page, D.L.2    Fleming, I.D.3
  • 26
    • 33751084640 scopus 로고    scopus 로고
    • PIK3CA mutation status in Japanese lung cancer patients
    • Kawano O, Sasaki H, Endo K, et al. PIK3CA mutation status in Japanese lung cancer patients. Lung Cancer. 2006;54(2): 209-215.
    • (2006) Lung Cancer , vol.54 , Issue.2 , pp. 209-215
    • Kawano, O.1    Sasaki, H.2    Endo, K.3
  • 27
    • 79953024710 scopus 로고    scopus 로고
    • Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer
    • Ludovini V, Bianconi F, Pistola L, et al. Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer. J Thorac Oncol. 2011;6(4): 707-715.
    • (2011) J Thorac Oncol , vol.6 , Issue.4 , pp. 707-715
    • Ludovini, V.1    Bianconi, F.2    Pistola, L.3
  • 28
    • 34548446446 scopus 로고    scopus 로고
    • PIK3CA mutation and amplification in human lung cancer
    • Okudela K, Suzuki M, Kageyama S, et al. PIK3CA mutation and amplification in human lung cancer. Pathol Int. 2007;57(10): 664-671.
    • (2007) Pathol Int , vol.57 , Issue.10 , pp. 664-671
    • Okudela, K.1    Suzuki, M.2    Kageyama, S.3
  • 29
    • 11144358645 scopus 로고    scopus 로고
    • High frequency of mutations of the PIK3CA gene in human cancers
    • doi:10.1126/science.1096502
    • Samuels Y, Wang Z, Bardelli A, et al. High frequency of mutations of the PIK3CA gene in human cancers. Science. 2004;304(5670): 554. doi:10.1126/science. 1096502.
    • (2004) Science , vol.304 , Issue.5670 , pp. 554
    • Samuels, Y.1    Wang, Z.2    Bardelli, A.3
  • 30
    • 84856823963 scopus 로고    scopus 로고
    • Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling
    • Chaft JE, Arcila ME, Paik PK, et al. Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling. Mol Cancer Ther. 2012;11(2): 485-491.
    • (2012) Mol Cancer Ther , vol.11 , Issue.2 , pp. 485-491
    • Chaft, J.E.1    Arcila, M.E.2    Paik, P.K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.